Skip to main content
SpringerLink
Log in

Antimicrobial susceptibility of intra-abdominal Gram-negative bacilli from Europe: SMART Europe 2008

  • Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

As part of the worldwide Study for Monitoring Antimicrobial Resistance Trends (SMART), a total of 3,030 clinical isolates of Gram-negative bacilli from intra-abdominal infections were collected from 43 hospital centres from 13 European countries during 2008. Of 51 species, the most commonly isolated species were Escherichia coli (49.3%), followed by Klebsiella pneumoniae (10.5%) and Pseudomonas aeruginosa (8.6%). Respectively, 17.9%, 11.6%, 5.5% and 4.5% of K. pneumoniae, E. coli, Proteus mirabilis and K. oxytoca were extended-spectrum beta-lactamase (ESBL)-positive. All isolates were tested using a panel of 12 antimicrobial agents, and susceptibilities were determined using European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoints. The most active agents against the study isolates (including those producing ESBLs) were amikacin, ertapenem and imipenem. Overall, with the exception of the carbapenems, most agents exhibited dramatically reduced susceptibilities against ESBL-positive and multi-drug-resistant isolates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Doshi RK, Patel G, Mackay R, Wallach F (2009) Healthcare-associated infections: epidemiology, prevention, and therapy. Mt Sinai J Med 76:84–94

    Article  PubMed  Google Scholar 

  2. Lockhart SR, Abramson MA, Beekmann SE, Gallagher G, Riedel S, Diekema DJ, Quinn JP, Doern GV (2007) Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. J Clin Microbiol 45:3352–3359

    Article  PubMed  Google Scholar 

  3. Mazuski JE, Solomkin JS (2009) Intra-abdominal infections. Surg Clin North Am 89:421-437

    Article  PubMed  Google Scholar 

  4. Cantón R, Novais A, Valverde A, Machado E, Peixe L, Baquero F, Coque TM (2008) Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 1:144–153

    Article  Google Scholar 

  5. Nijssen S, Florijn A, Bonten MJ, Schmitz FJ, Verhoef J, Fluit AC (2004) Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. Int J Antimicrob Agents 24:585–591

    Article  CAS  PubMed  Google Scholar 

  6. Bochicchio GV, Baquero F, Hsueh PR, Paterson DL, Rossi F, Snyder TA, McCarroll K, Satishchandran V, Dinubile MJ, Chow JW (2006) In vitro susceptibilities of Escherichia coli isolated from patients with intra-abdominal infections worldwide in 2002–2004: results from SMART (Study for Monitoring Antimicrobial Resistance Trends). Surg Infect 7:537–545

    Article  Google Scholar 

  7. Reinert RR, Low DE, Rossi F, Zhang X, Wattal C, Dowzicky MJ (2007) Antimicrobial susceptibility among organisms from the Asia/Pacific rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline. J Antimicrob Chemother 60:1018–1029

    Article  CAS  PubMed  Google Scholar 

  8. Nijssen S, Florijn A, Bonten MJ, Schmitz FJ, Verhoef J, Fluit AC (2004) Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. Int J Antimicrob Agents 24:585–591

    Article  CAS  PubMed  Google Scholar 

  9. Turner PJ (2008) Meropenem activity against European isolates: report on the MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) 2006 results. Diagn Microbiol Infect Dis 60:185–192

    Article  CAS  PubMed  Google Scholar 

  10. European Antibiotic Resistance Surveillance System (EARSS). Home page at: http://www.rivm.nl/earss/

  11. Coque TM, Baquero F, Canton R (2008) Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill 13(47):pii=19044

    PubMed  Google Scholar 

  12. Valverde A, Grill F, Coque TM, Pintado V, Baquero F, Cantón R, Cobo J (2008) High rate of intestinal colonization with extended-spectrum-beta-lactamase-producing organisms in household contacts of infected community patients. J Clin Microbiol 46:2796–2799

    Article  PubMed  Google Scholar 

  13. Clinical Laboratory Standards Institute (CLSI) (2006) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard—Seventh Edition, Document M7-A7. CLSI, 940 West Valley Road, Suite 1400, Wayne, PA 19087-1898, USA

  14. European Committee on Antimicrobial Susceptibility Testing (EUCAST). Home page at: http://www.eucast.org

  15. Clinical Laboratory Standards Institute (CLSI) (2009) Performance Standards for Antimicrobial Susceptibility Testing, Document M100-S19. CLSI, 940 West Valley Road, Suite 1400, Wayne, PA 19087-1898, USA

  16. Pournaras S, Protonotariou E, Voulgari E, Kristo I, Dimitroulia E, Vitti D, Tsalidou M, Maniatis AN, Tsakris A, Sofianou D (2009) Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece. J Antimicrob Chemother 64:348–352

    Article  CAS  PubMed  Google Scholar 

  17. Kristinsson KG, Monnet DL (2008) Increasing multidrug resistance and limited treatment options: situation and initiatives in Europe. Euro Surveill 13(47):pii=19043

    PubMed  Google Scholar 

  18. Goren MG, Carmeli Y, Schwaber MJ, Chmelnitsky I, Schechner V, Navon-Venezia S (2010) Transfer of carbapenem-resistant plasmid from Klebsiella pneumoniae ST258 to Escherichia coli in patient. Emerg Infect Dis 16:1014–1017

    CAS  PubMed  Google Scholar 

  19. Curiao T, Morosini MI, Ruiz-Garbajosa P, Robustillo A, Baquero F, Coque TM, Cantón R (2010) Emergence of blaKPC-3-Tn4401a associated with a pKPN3/4-like plasmid within ST384 and ST388 Klebsiella pneumoniae clones in Spain. J Antimicrob Chemother 65:1608–1614

    Article  CAS  PubMed  Google Scholar 

  20. Souli M, Galani I, Antoniadou A, Papadomichelakis E, Poulakou G, Panagea T, Vourli S, Zerva L, Armaganidis A, Kanellakopoulou K, Giamarellou H (2010) An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes. Clin Infect Dis 50:364–373

    Article  CAS  PubMed  Google Scholar 

  21. Souli M, Galani I, Giamarellou H (2008) Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. Euro Surveill 13(47):pii=19045

    PubMed  Google Scholar 

  22. Kassis-Chikhani N, Decré D, Gautier V, Burghoffer B, Saliba F, Mathieu D, Samuel D, Castaing D, Petit JC, Dussaix E, Arlet G (2006) First outbreak of multidrug-resistant Klebsiella pneumoniae carrying bla VIM-1 and bla SHV-5 in a French university hospital. J Antimicrob Chemother 57:142–145

    Article  CAS  PubMed  Google Scholar 

  23. Ktari S, Arlet G, Mnif B, Gautier V, Mahjoubi F, Ben Jmeaa M, Bouaziz M, Hammami A (2006) Emergence of multidrug-resistant Klebsiella pneumoniae isolates producing VIM-4 metallo-β-lactamase, CTX-M-15 extended-spectrum β-lactamase, and CMY-4 AmpC β-lactamase in a Tunisian university hospital. Antimicrob Agents Chemother 50:4198–4201

    Article  CAS  PubMed  Google Scholar 

  24. Tokatlidou D, Tsivitanidou M, Pournaras S, Ikonomidis A, Tsakris A, Sofianou D (2008) Outbreak caused by a multidrug-resistant Klebsiella pneumoniae clone carrying bla VIM-12 in a university hospital. J Clin Microbiol 46:1005–1008

    Article  CAS  PubMed  Google Scholar 

  25. Falagas ME, Karageorgopoulos DE (2008) Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology. Clin Infect Dis 46:1121–1122

    Article  PubMed  Google Scholar 

  26. Falagas ME, Bliziotis IA (2007) Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era? Int J Antimicrob Agents 29:630–636

    Article  CAS  PubMed  Google Scholar 

  27. Navon-Venezia S, Leavitt A, Carmeli Y (2007) High tigecycline resistance in multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother 59:772–774

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

SH works for IHMA Europe, a wholly owned subsidiary of International Health Management Associates, Inc. (IHMA). DH, SB and RB all work for IHMA, Inc., which is paid to coordinate/manage the SMART programme. YC is part of Merck’s “Speaker Bureau”. PH has no conflicts.

Parts of this work were presented in Poster E-1477 at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2009), San Francisco, CA, September 2009 (“Global Susceptibility Patterns of E. coli from Intra-Abdominal Infections to Ertapenem and Comparators—SMART 2008”).

Author information

Authors and Affiliations

  1. IHMA Europe Sàrl, 4 Route de la Corniche, 1066, Epalinges, Switzerland

    S. Hawser

  2. International Health Management Associates, Inc., Schaumburg, IL, USA

    D. Hoban, S. Bouchillon & R. Badal

  3. Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

    Y. Carmeli

  4. University of Birmingham, Edgbaston, Birmingham, UK

    P. Hawkey

  5. Health Protection Agency, Birmingham, UK

    P. Hawkey

Authors
  1. S. Hawser
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Hoban
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Bouchillon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Badal
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Y. Carmeli
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P. Hawkey
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Hawser.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hawser, S., Hoban, D., Bouchillon, S. et al. Antimicrobial susceptibility of intra-abdominal Gram-negative bacilli from Europe: SMART Europe 2008. Eur J Clin Microbiol Infect Dis 30, 173–179 (2011). https://doi.org/10.1007/s10096-010-1066-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-010-1066-0

Keywords

Search

Navigation